PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32209436-3	2020	In this study, we demonstrate that co-administered glycine improves phosphorodiamidate morpholino oligomer (PMO) potency in mdx mice with marked functional improvement and an up to 50-fold increase of dystrophin in abdominal muscles compared to PMO in saline.	Glycine	51-58	dystrophin, muscular dystrophy	Mus musculus	201-211	
35393769-5	2022	Here, we demonstrate that the combination of oral glycine and metformin with intravenous PMO enhances PMO activity, dystrophin restoration, extends lifespan, and improves body-wide function and phenotypic rescue of dystrophin /utrophin double knock-out (DKO) mice without any overt adverse effects.	Glycine	50-57	dystrophin, muscular dystrophy	Mus musculus	116-126	
35393769-5	2022	Here, we demonstrate that the combination of oral glycine and metformin with intravenous PMO enhances PMO activity, dystrophin restoration, extends lifespan, and improves body-wide function and phenotypic rescue of dystrophin /utrophin double knock-out (DKO) mice without any overt adverse effects.	Glycine	50-57	dystrophin, muscular dystrophy	Mus musculus	215-225	
31506484-0	2019	Glycine administration attenuates progression of dystrophic pathology in prednisolone-treated dystrophin/utrophin null mice.	Glycine	0-7	dystrophin, muscular dystrophy	Mus musculus	94-104